0001493152-23-023816.txt : 20230706
0001493152-23-023816.hdr.sgml : 20230706
20230706161511
ACCESSION NUMBER: 0001493152-23-023816
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230101
FILED AS OF DATE: 20230706
DATE AS OF CHANGE: 20230706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KNIGHT PETER S
CENTRAL INDEX KEY: 0001189792
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41463
FILM NUMBER: 231073751
MAIL ADDRESS:
STREET 1: 6702 STEIN CIRCLE, #642
STREET 2: P.O. BOX 4138
CITY: PARK CITY
STATE: UT
ZIP: 84060
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: bioAffinity Technologies, Inc.
CENTRAL INDEX KEY: 0001712762
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 465211056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22211 WEST INTERSTATE-10
STREET 2: SUITE 1206
CITY: SAN ANTONIO
STATE: TX
ZIP: 78257
BUSINESS PHONE: 210-698-5334
MAIL ADDRESS:
STREET 1: 22211 WEST INTERSTATE-10
STREET 2: SUITE 1206
CITY: SAN ANTONIO
STATE: TX
ZIP: 78257
4
1
ownership.xml
X0407
4
2023-01-01
0
0001712762
bioAffinity Technologies, Inc.
BIAF
0001189792
KNIGHT PETER S
C/O BIOAFFINITY TECHNOLOGIES, INC.
22211 WEST INTERSTATE 10, SUITE 1206
SAN ANTONIO,
TX
78257
1
0
0
0
0
Common Stock
2023-01-01
4
A
0
8227
2.28
A
30675
D
Common Stock
2023-04-15
4
A
0
9920
1.89
A
40595
D
Common Stock
2023-07-01
4
A
0
10245
1.83
A
50840
D
Represents a grant from bioAffinity Technologies, Inc. (the "Issuer") to Mr. Knight of 8,227 restricted shares of common stock, par value $0.007 (the "Common Stock"), on January 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.
Represents a grant from the Issuer to Mr. Knight of 9,920 restricted shares of Common Stock on April 15, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest one-third on the date of grant, one-third on May 1, 2023 and the remaining shares on June 1, 2023, provided Mr. Knight continues to serve as a director, and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.
Represents a grant from the Issuer to Mr. Knight of 10,245 restricted shares of Common Stock, on July 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.
/s/ Peter S. Knight
2023-07-05